Cerebral Microangiopathy: Causes, Consequences, and Clinical Impact

Cerebral small vessel disease (CSVD) / microangiopathy involves pathological changes in perforating arterioles, capillaries, venules:

  • Lipohyalinosis (hypertension) → vessel wall thickening, luminal narrowing.
  • Cerebral amyloid angiopathy (CAA): Amyloid-β deposition → vessel fragility (lobar microbleeds).
  • Genetic: CADASIL (NOTCH3), CARASIL, COL4A1/2.

Neuroimaging Markers

  • White matter hyperintensities (WMH) / leukoaraiosis.
  • Lacunar infarcts (3–15 mm).
  • Microbleeds (SWI/GRE).
  • Perivascular spaces (dilated).
  • Brain atrophy.

Clinical Syndromes

  • Vascular cognitive impairment (VCI) → vascular dementia (multi-infarct, subcortical ischemic).
  • Gait disturbance, urinary incontinence, executive dysfunction.
  • Stroke risk ↑ (lacunar, hemorrhagic).

Management

  • Strict BP control (<130/80 per SPRINT-MIND).
  • Statin, antiplatelet (secondary prevention), diabetes control.
  • Lifestyle: exercise, Mediterranean diet, smoking cessation.
  • Symptomatic: cholinesterase inhibitors for dementia; rehab for gait.

Brain & Nervous System - Related Articles